FDA Inspection 1286134 — Adam M. Brufsky, M.D., Ph.D
The FDA completed an inspection of Adam M. Brufsky, M.D., Ph.D on Sep 24, 2025 in Pittsburgh, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 24, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Pittsburgh, PA (United States)
Additional Details
Clinical Investigator (CI)